Bonapharm S.a.c.... Pharmaceutical Import Profile — Peru (DGFT 2022–2026)

Name: Bonapharm S.a.c.... Pharmaceutical Import Records from India — 3 Products, $4.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Bonapharm S.a.c.... — Pharmaceutical Importer Profile (2026) | 3 Products, $4.2M Trade | TransData Nexus

Bonapharm S.a.c....

Pharmaceutical Importer · Peru · Analgesics & Antipyretics Focus · $4.2M Total Trade · DGFT Verified

Bonapharm S.a.c.... is a pharmaceutical importer based in Peru with a total trade value of $4.2M across 3 products in 3 therapeutic categories. Based on 87 verified import shipments from Indian Customs (DGFT) records, Bonapharm S.a.c.... is the #1 buyer in 1 product including Dextromethorphan. Bonapharm S.a.c.... sources from 6 verified Indian suppliers, with Softgel Healthcare Private Limited accounting for 43.7% of imports.

Bonapharm S.a.c.... — Import Portfolio & Supplier Network

Bonapharm S.a.c.... import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Bonapharm S.a.c....?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Softgel Healthcare Private Limited	$3.3M	140	43.7%
The Madras Pharmaceuticals	$2.5M	146	33.8%
Steril-gene Life Sciences Private Limited

What Formulations Does Bonapharm S.a.c.... Import?

Formulation	Value	Ships
Gripacheck capsules (25x4`s)	$333.4K	8
Gripacheck capsules (acetaminophen USP	$304.8K	7
Gripacheck CAPS (acetaminophen USP 325MG	$200.0K	4
Clincheck 300 MG capsules (clindamycin capsules BP 300 MG)	$189.3K	7
Dolocheck plus 400 MG capsules	$155.5K	6
Pregabalina 150 MG capsules (pregabalincapsules 150 MG)	$142.8K	4
Damicocyn 1.5 MG tablets (levonorgestrelbp 1.5 MG)	$128.8K	7
Damicocyn 1.5 MG tablets	$115.2K	4
Clondicyn 300 MG capsules (clindamycin	$102.1K	3
Clincheck 300 MG capsules (clindamycin	$101.9K	5
Plidocheck plus 400 MG	$100.0K	2
Gripacheck CAPS(acetaminophen USP 325MG	$100.0K	2
Gripacheck capsules (acetaminophen USP 325 MG, dextromethorphan hydrobromide usp10 MG phenylephrine hcl USP 5 MG	$93.1K	3
Gripacheck capsules (acetaminophen USP 325 mgdextromethorphan hydrobromide usp10 MG phenylephrine hcl USP 5 MG)	$91.2K	3
Gripacheck capsules (acetaminophen USP 325MG dextromethorphan hydrobromide usp10mg phenylephrine hcl USP 5 MG	$90.7K	3

Bonapharm S.a.c.... imports 249 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Acetaminophen	Analgesics & Antipyretics	$1.8M	36	0.8%	15
2	Dextromethorphan	Respiratory & OTC	$1.2M	27	5.8%	1
3	Levothyroxine	Diabetes & Endocrine	$1.2M	24	1.5%	3

Bonapharm S.a.c.... imports 3 pharmaceutical products across 3 categories into Peru totaling $4.2M. The company is the #1 buyer for 1 product: Dextromethorphan.

Bonapharm S.a.c.... — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Bonapharm S.A.C. is a Peruvian pharmaceutical company specializing in the development, production, and distribution of a diverse range of pharmaceutical and over-the-counter (OTC) products. Established through the merger of Pharmacheck Perú and Laboratorios Bonafide, Bonapharm has rapidly ascended to a leading position in the Peruvian market. The company is headquartered at Av. Del Pinar 180 – Of. 701, Santiago de Surco, Lima, Peru.

With a portfolio exceeding 100 pharmaceutical molecules and OTC products, Bonapharm has achieved significant market penetration, becoming one of the top-selling brands in Peru. The company's strategic focus on developing bioequivalent and interchangeable products, particularly in the probiotic and soft capsule segments, has been instrumental in its growth. This approach has not only enhanced product accessibility but also improved profit margins for distributors and pharmacies.

2Distribution Network

Bonapharm's distribution network is robust, encompassing operations in Peru, Ecuador, and Bolivia. The company's headquarters in Lima serve as the central hub for its logistics and distribution activities. While specific details about warehouse locations and logistics capabilities are not publicly disclosed, Bonapharm's expansion into neighboring countries indicates a well-established distribution infrastructure capable of supporting regional operations.

3Industry Role

In Peru's pharmaceutical supply chain, Bonapharm S.A.C. functions primarily as a wholesaler and distributor. The company's extensive product portfolio and market presence position it as a key player in the distribution of pharmaceutical and OTC products. Bonapharm's role is pivotal in ensuring the availability of a wide range of medications and health products to consumers across the region.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Bonapharm S.a.c....

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Bonapharm's sourcing strategy exhibits a high degree of concentration, with a significant portion of its pharmaceutical imports originating from India. Between 2022 and 2026, the company imported finished pharmaceutical formulations valued at $4.2 million USD from India, accounting for 87 shipments. The top three imported products—acetaminophen, dextromethorphan, and levothyroxine—collectively represent 100% of the company's Indian pharmaceutical imports. This concentration suggests a strategic choice to leverage India's competitive pricing and manufacturing capabilities. However, such dependency on a single source may pose risks related to supply chain disruptions, currency fluctuations, and geopolitical factors. The stability of Bonapharm's relationship with its Indian suppliers, including SOFTGEL HEALTHCARE PRIVATE LIMITED, THE MADRAS PHARMACEUTICALS, and STERIL-GENE LIFE SCIENCES PRIVATE LIMITED, is crucial to mitigate these risks.

2Supply Chain Resilience

Bonapharm's supply chain resilience is closely tied to its reliance on Indian suppliers for finished pharmaceutical formulations. The company's portfolio concentration on a few key products indicates a streamlined procurement process but also highlights potential vulnerabilities. The absence of publicly available information regarding backup suppliers and the diversity of formulations imported suggests that Bonapharm may face challenges in maintaining supply continuity during disruptions. Additionally, the company's exposure to specific shipping routes and its suppliers' adherence to international regulatory standards, such as WHO Good Manufacturing Practices (GMP), are critical factors influencing supply chain stability.

Importing Pharmaceuticals into Peru — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Peru

1Regulatory Authority & Framework

In Peru, the regulatory authority overseeing pharmaceutical imports is the General Directorate of Medicines, Supplies, and Drugs (DIGEMID), operating under the Ministry of Health. DIGEMID is responsible for ensuring the safety, efficacy, and quality of pharmaceutical products entering the Peruvian market. Key legislation governing pharmaceutical imports includes the General Health Law and the Pharmaceutical Products Regulation, which outline the requirements for marketing authorization, importation, and distribution of pharmaceutical products. The marketing authorization pathway for Indian generics involves obtaining approval from DIGEMID, which includes submitting comprehensive documentation on product quality, safety, and efficacy, as well as compliance with GMP standards.

2Import Licensing & GMP

Import licensing requirements in Peru stipulate that pharmaceutical products must be registered with DIGEMID before entering the market. This process involves providing evidence of GMP certification from the manufacturing facility, which must be recognized by DIGEMID. GMP certificates from reputable international bodies, such as the European Union (EU), World Health Organization (WHO), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S), are generally accepted. Indian exporters seeking to supply Bonapharm and the broader Peruvian market must ensure that their manufacturing facilities hold valid GMP certifications from these recognized organizations. Additionally, obtaining wholesale distribution authorization from DIGEMID is essential for legal distribution within Peru.

Bonapharm S.a.c.... — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Bonapharm's product strategy focuses on therapeutic areas with high market demand and growth potential. The company's top three imported product categories—Analgesics & Antipyretics, Respiratory & OTC, and Diabetes & Endocrine—collectively account for 100% of its Indian pharmaceutical imports. This strategic focus aligns with prevalent health concerns in Peru, such as pain management, respiratory conditions, and endocrine disorders like diabetes. By concentrating on these therapeutic areas, Bonapharm addresses significant consumer needs and positions itself as a key provider of essential medications in the Peruvian market.

2Sourcing Profile

Bonapharm's sourcing strategy emphasizes the procurement of generic drugs, particularly in the analgesics, respiratory, and endocrine therapeutic categories. The company's preference for finished pharmaceutical formulations, as opposed to raw active pharmaceutical ingredients (APIs), indicates a focus on ready-to-market products that can be swiftly distributed to meet consumer demand. India's established reputation for producing high-quality generic medications at competitive prices makes it a strategic sourcing partner for Bonapharm. This approach enables Bonapharm to offer a diverse range of affordable and effective pharmaceutical products to the Peruvian market.

3Market Positioning

Seller's Guide — How to Become a Supplier to Bonapharm S.a.c....

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

For new Indian suppliers, Bonapharm's concentrated sourcing pattern presents both opportunities and challenges. The company's established relationships with current Indian suppliers may limit the potential for new entrants. However, Bonapharm's focus on specific therapeutic areas and product categories indicates potential gaps in its sourcing strategy, particularly in emerging or underserved segments. Indian exporters with innovative products or those meeting unmet market needs may find opportunities to collaborate with Bonapharm, provided they can adhere to the company's quality standards and regulatory requirements.

2Requirements & Qualifications

Indian exporters aiming to supply Bonapharm and the Peruvian market must ensure compliance with several key requirements. Manufacturing facilities must hold valid GMP certifications from recognized international bodies, such as the EU, WHO, or PIC/S. Products must be registered with DIGEMID, necessitating the submission of comprehensive documentation on product quality, safety, and efficacy. Labeling must be in Spanish and include all mandated information. Additionally, obtaining wholesale distribution authorization from DIG

Frequently Asked Questions — Bonapharm S.a.c....

What products does Bonapharm S.a.c.... import from India?

Bonapharm S.a.c.... imports 3 pharmaceutical products across 3 categories. Top imports: Acetaminophen ($1.8M), Dextromethorphan ($1.2M), Levothyroxine ($1.2M).

Who supplies pharmaceuticals to Bonapharm S.a.c.... from India?

Bonapharm S.a.c.... sources from 6 verified Indian suppliers. The primary supplier is Softgel Healthcare Private Limited (43.7% of imports, $3.3M).

What is Bonapharm S.a.c....'s total pharmaceutical import value?

Bonapharm S.a.c....'s total pharmaceutical import value from India is $4.2M, based on 87 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Bonapharm S.a.c.... focus on?

Bonapharm S.a.c.... imports across 3 categories. The largest: Analgesics & Antipyretics (42.7%), Respiratory & OTC (28.8%), Diabetes & Endocrine (28.5%).

Get Full Bonapharm S.a.c.... Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 3 company name variants from customs records. For current shipment-level data, contact TransData Nexus.